Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20218425 20175191 1.84 50 Palliative (P) 2019-03-13 2019-03-26 null 02 N CARBOPLATIN + ETOPOSIDE 101665187
20218442 20175192 1.79 55 null null 2020-06-07 Panitumumab 02 null PANITUMUMAB 100106734
20218484 20175193 1.72 58.7 Palliative (P) 2018-05-02 2018-11-14 NIVOLUMAB 02 N NIVOLUMAB 100819810
20218491 20175194 1.81 69.6 null 2020-04-09 2022-01-30 ECX 2 N ECX 101366781
20218493 20175195 1.63 46 Adjuvant (A) null 2019-03-12 null null N PANITUMUMAB 100056429
20218510 20175196 1.57 57.5 null 2017-11-15 2017-11-15 CARBOPLATIN + ETOPOSIDE 02 null CARBOPLATIN + ETOPOSIDE 100314820
20218522 20175197 null 81.4 Palliative (P) 2018-10-07 2018-10-15 Carboplatin + Etoposide IV 3 day 02 N CARBOPLATIN + ETOPOSIDE 100435267
20218546 20175198 1.51 71.8 null 2018-06-18 2019-09-28 Cisplatin +Fluorouracil (3 wk) 02 N CISPLATIN + FLUOROURACIL 100814559
20218554 20175199 1.73 null Neo-adjuvant (N) 2017-03-16 2017-04-06 null 02 N CARBOPLATIN + ETOPOSIDE 100542741
20218579 20175200 1.61 81 null 2020-04-13 2020-04-25 NIVOLUMAB 02 null NIVOLUMAB 101507534
20218596 20175201 1.55 98 null 2016-12-27 2017-01-12 ECX N null ECX 101515166
20218606 20175202 null null Curative (C) 2019-02-03 2019-02-03 NIVOLUMAB 02 null NIVOLUMAB 100927037
20218649 20175203 1.63 88.4 Neo-adjuvant (N) 2022-03-23 2022-04-20 Carboplatin + Etoposide IV 3 day N N CARBOPLATIN + ETOPOSIDE 100631581
20218650 20175204 null 84.4 Neo-adjuvant (N) null 2020-11-21 null 02 N CARBOPLATIN + ETOPOSIDE 101314823
20218677 20175205 1.57 140 null 2018-10-04 2018-10-17 ECX 2 N ECX 100423707
20218703 20175206 1.9 98 Adjuvant (A) 2017-01-03 2017-01-03 null 02 null NIVOLUMAB 101169018
20218706 20175207 1.62 76.7 Palliative (P) null 2017-08-18 null 02 N CARBOPLATIN + ETOPOSIDE 101857138
20218736 20175208 1.75 79 Palliative (P) 2017-07-31 2017-07-31 CISPLATIN + FLUOROURACIL 02 N CISPLATIN + FLUOROURACIL 100703421
20218756 20175209 1.75 63.5 null 2016-08-04 2016-08-20 ECX N null ECX 101326076
20218764 20175210 null 62.3 null 2019-07-29 2019-07-30 NIVOLUMAB null null NIVOLUMAB 101781052
20218793 20175211 1.67 null null 2021-04-17 2021-04-29 Carboplatin + Etoposide iv&po 02 null CARBOPLATIN + ETOPOSIDE 101440901
20218807 20175212 1.8 79.5 Neo-adjuvant (N) 2016-09-02 2016-09-17 Panitumumab 02 N PANITUMUMAB 100772723
20218808 20175213 1.47 82.3 Neo-adjuvant (N) 2021-10-07 2021-10-08 null 02 N PANITUMUMAB 100172881
20218868 20175214 1.7 101 Palliative (P) 2020-02-13 2020-03-05 CISPLATIN + FLUOROURACIL 02 null CISPLATIN + FLUOROURACIL 101861290
20218898 20175216 1.73 66.2 Palliative (P) 2017-06-16 2017-07-03 NIVOLUMAB 02 N NIVOLUMAB 101049482
20218909 20175217 1.84 62 null 2017-04-16 2018-06-04 NIVOLUMAB 02 N NIVOLUMAB 101780442
20218934 20175218 1.78 90.35 03 null 2021-12-29 Panitumumab 02 N PANITUMUMAB 101756647
20218942 20175219 1.76 59 Curative (C) null 2019-03-12 null 02 N CARBOPLATIN + ETOPOSIDE 100197295
20218978 20175221 1.64 64.7 Palliative (P) 2019-08-26 2019-09-06 null 2 N CARBOPLATIN + ETOPOSIDE 100886759
20219015 20175223 1.72 null Palliative (P) 2018-09-04 2018-09-17 null null null CARBOPLATIN + ETOPOSIDE 100687325
20219051 20175224 1.69 95.5 Curative (C) 2018-05-04 2018-10-22 null N N ECX 101650398
20219081 20175225 1.56 63 null 2017-11-17 2018-09-15 null 2 null CISPLATIN + FLUOROURACIL 100398303
20219101 20175226 1.6 50.7 Palliative (P) null 2016-06-17 IRINOTECAN + MDG + PANITUMUMAB Y N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100193102
20219158 20175227 1.73 86.9 Neo-adjuvant (N) 2018-03-01 2018-03-05 Oxaliplatin + Raltitrexed 02 Y OXALIPLATIN + RALTITREXED 100698607
20219163 20175228 1.55 62 Palliative (P) 2019-11-12 2019-11-12 EOX 02 N CETUXIMAB + IRINOTECAN + MDG 101715870
20219184 20175229 1.81 69.35 Adjuvant (A) 2020-08-13 2020-08-21 EOX 2 N CAPECITABINE + RT 100180009
20219191 20175230 1.71 88.3 null 2018-09-08 2019-07-14 Trial Unspecified N null TRIAL 100164717
20219230 20175231 1.76 78.1 Neo-adjuvant (N) null 2017-12-24 IRINOTECAN + MDG + PANITUMUMAB 02 Y FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101308545
20219266 20175232 1.59 63.35 null 2016-05-11 2016-06-08 Sorafenib 2 null SORAFENIB 100529918
20219290 20175233 1.76 75 Disease modification (D) 2017-05-04 2017-05-09 Cetuximab + FOLFIRI cycle 2 onwards 02 Y CETUXIMAB + IRINOTECAN + MDG 101059105
20219321 20175234 1.75 45.7 Palliative (P) 2022-01-26 2022-02-15 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101580980
20219322 20175235 1.83 71.4 null 2021-05-05 2021-06-17 EOX 02 null OXALIPLATIN + RALTITREXED 101850825
20219337 20175236 1.7 88.3 null 2021-05-17 2021-05-17 CAPECITABINE + RT 2 null CAPECITABINE + RT 100572151
20219351 20175237 1.55 91 null 2018-07-26 2018-08-16 CETUXIMAB + IRINOTECAN + MDG 2 null CETUXIMAB + IRINOTECAN + MDG 101564360
20219368 20175238 1.66 59 null 2019-04-12 2019-05-11 EOX 2 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100323023
20219374 20175239 1.85 79.4 Neo-adjuvant (N) null 2019-09-23 Oxaliplatin + Raltitrexed N Y OXALIPLATIN + RALTITREXED 101121897
20219389 20175240 1.7 62.9 null 2016-05-07 2016-05-17 EOX 02 null TRIAL 100561204
20219400 20175241 1.92 71 Palliative (P) 2018-12-13 2020-08-02 EOX N null CAPECITABINE + RT 101628008
20219403 20175242 1.79 null Palliative (P) 2017-03-30 2017-04-19 Sorafenib 01 N SORAFENIB 100584316
20219416 20175243 1.78 60.5 null 2017-07-18 2017-07-19 IRINOTECAN + MDG + PANITUMUMAB N null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101466062